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Abstract 
A great deal of attention has been focused on adverse effects of tobacco smoking on conception, pregnancy, fetal, 
and child health. The aim of this paper is to discuss the current evidence regarding short and long-term health effects 
on child health of parental smoking during pregnancy and lactation and the potential underlying mechanisms. Stud-
ies were searched on MEDLINE® and Cochrane database inserting, individually and using the Boolean ANDs and ORs, 
‘pregnancy’, ‘human lactation’, ‘fetal growth’, ‘metabolic outcomes’, ‘obesity’, ‘cardiovascular outcomes’, ‘blood pressure’, 
‘brain development’, ‘respiratory outcomes’, ‘maternal or paternal or parental tobacco smoking’, ‘nicotine’. Publications 
coming from the reference list of studies were also considered from MEDLINE. All sources were retrieved between 
2015-01-03 and 2015-31-05. There is overall consistency in literature about negative effects of fetal and postnatal 
exposure to parental tobacco smoking on several outcomes: preterm birth, fetal growth restriction, low birth weight, 
sudden infant death syndrome, neurodevelopmental and behavioral problems, obesity, hypertension, type 2 diabe-
tes, impaired lung function, asthma and wheezing. While maternal smoking during pregnancy plays a major role on 
adverse postnatal outcomes, it may also cumulate negatively with smoking during lactation and with second-hand 
smoking exposure. Although this review was not strictly designed as a systematic review and the PRISMA Statement 
was not fully applied it may benefit the reader with a promptly and friendly readable update of the matter. This review 
strengthens the need to plan population health policies aimed to implement educational programs to hopefully 
minimize tobacco smoke exposure during pregnancy and lactation.
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Background
Great attention has been focused on adverse effects of 
tobacco smoking on health, also early in life [1]. Although 
a decrease in smoking prevalence among pregnant 
women has been observed in almost all Western coun-
tries [1] the prevalence is far from the 2 % goal fixed by 
“Healthy People—2010” in USA [2]. Indeed, the Euro-
pean perinatal health report showed that more than 10 % 
of women smoke during pregnancy with values ranging 
from 5 % in Lithuania to 22 % in France [3].
Tobacco smoke is a complex, dynamic and reactive 
mixture containing an estimated 5000 chemicals [4]. 
Tobacco smoke is an aerosol of liquid droplets (the 
particulate phase) suspended in a mixture of gases and 
semi-volatile compounds [5]. The particulate phase is 
characterized by several compounds, such as the poly-
cyclic aromatic hydrocarbons, tobacco-specific nitrosa-
mines, phytosterols and metals [5]. Some compounds, 
termed semi-volatiles, e.g. phenol and the cresols 
(phenolics), are distributed between the particulate 
and gaseous phases [5]. The gaseous phase contains 
mainly nitrogen and oxygen but also several combus-
tion products, such as carbon monoxide (CO), carbon 
dioxide and nitric oxide [5]. Nicotine, an alkaloid pro-
duced in the roots of the tobacco plant, is the crucial 
addictive compound of tobacco smoke [6]. It is the 
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most important pharmacologically active compound in 
tobacco smoke [5].
Aim of the review
Currently there is lack of reviews amalgamating short 
and long-term effects on child health of maternal and 
paternal smoking early in life. The aim of this paper is 
to discuss the current evidence regarding the short and 
long-term health effects of parental smoking during 
pregnancy and lactation and the potential underlying 
mechanisms.
Methodology
Eligibility criteria
The populations of interest were children from birth to 
18 years, their mothers (during pregnancy and lactation) 
and fathers. Inclusion criteria were: type of article (meta-
analysis, multicenter study, review, systematic review, 
observational study, case–control study, longitudinal/
prospective study, retrospective study, randomized con-
trolled trial), publication date (2005–2015), species (both 
human and animal), English language. Texts available 
only on abstract form were excluded.
Information sources, search strategy and study selection
Publications were searched on MEDLINE® and 
Cochrane database inserting terms individually and using 
the Boolean ANDs and ORs. Other publications coming 
from the reference list of studies extracted from MED-
LINE, Cochrane database and from the personal refer-
ence databases of the authors were also evaluated. In 
the search strategy the following terms were included: 
‘pregnancy’, ‘human lactation’, ‘fetal growth’, ‘metabolic 
outcomes’, ‘obesity’, ‘cardiovascular outcomes’, ‘blood 
pressure’, ‘brain development’, ‘respiratory outcomes’, 
‘maternal or paternal or parental tobacco smoking’, ‘nico-
tine’. All sources were retrieved between 2015-01-03 and 
2015-31-05. The data screening and extraction were con-
ducted independently by two authors and any variances 
resolved between them.
Parental tobacco smoking during pregnancy
It is well known that maternal smoking during pregnancy 
is associated with several fetal and developmental com-
plications with increased risk of significant long-term 
consequences [7]. Indeed, nicotine is able to cross the 
placenta and therefore may affect fetal development [6]. 
Several other substances contained in tobacco smoke 
may cross the placenta and enter the fetal circulation, 
as CO which can interfere with the unborn child’s oxy-
gen supply, or polycyclic aromatic hydrocarbons and 
tobacco-specific nitrosamines [8].
Fetal growth
Smoking during pregnancy has important effects on fetal 
growth. Several studies have shown that maternal smok-
ing during pregnancy could decrease birth weight and 
significantly increases the risk of low birth weight births 
(<2500  g, LBW) and preterm birth [9–11] showing also 
dose-dependent and time specific associations [9, 11]. 
Recently resulted that for each additional pack smoked 
during pregnancy, there was a 2.8-g decrease in neonatal 
body mass (0.7-g decrease in fatty mass and 2.1 g decrease 
in free-fatty mass), showing a dose-dependent associa-
tion between prenatal smoking and neonatal body mass 
composition [11]. Moreover the paternal smoking and 
the environmental tobacco smoke may have a role. The 
effect of paternal smoking on small for gestational age 
(SGA) and LBW has been evaluated in several studies but 
there are inconsistent results [9], although a significant 
association with environmental tobacco exposure was 
observed [12]. Different mechanisms have been suggested 
to explain how maternal smoking may affect intrauterine 
growth and birth weight. CO, contained in tobacco, has 
a great affinity to hemoglobin and accordingly increases 
carboxyhemoglobin levels in umbilical arteries, inhibiting 
oxygen delivery to the cells and causing fetal hypoxia [9]. 
Moreover it has been showed that the resistance indices 
of uterine arteries and umbilical artery rised in accord-
ance with increasing levels of tobacco smoking expo-
sure in a dose-dependent manner [13]. Low weight birth 
could be the effect of the increase in resistance indices 
with consequent reduced amount of blood and oxygen 
transported to the fetus [13]. However, CO has also great 
affinity to the other biological molecules that bind oxygen 
such as myoglobin, cytochrome P450 and cytochrome c 
oxidase (COX), or mitochondrial respiratory chain com-
plex IV [14]. The observed increase in apoptosis seems to 
be caused probably by mitochondrial dysfunction due to 
CO-mediated COX inhibition [14].
Moreover, maternal smoking could be related to doco-
sahexaenoic acid (DHA) supply to fetus. Indeed mater-
nal smoking during pregnancy may progressively impair 
DHA synthesis and/or maternal transfer that has been 
associated with restricted fetal growth [15].
Lastly, fetal growth restriction due to tobacco smoking 
in pregnancy could also be the result of epigenetic mech-
anisms. Indeed exposure to tobacco smoke in utero has 
been related with changes in DNA methylation of genes 
associated with growth restriction (e.g. CYP1A1 pro-
moter) [16–18].
Brain development
Maternal smoking can modulate fetal brain develop-
ment and function. A reduced brain size and alterations 
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in brain functions were observed in infants exposed to 
prenatal smoking compared to unexposed infants [19]. 
Moreover, in the same review, a meta-analysis of nine 
papers with information on prenatal smoking exposure 
and head circumference at birth reported that, on aver-
age, the head circumference of the infants exposed to 
maternal smoking during pregnancy was 0.5 cm smaller 
than the unexposed [19]. The underlying mechanisms 
of these effects might include the nicotine modulating 
axonal path finding, synapse formation in neurons and 
CO leading to fetal hypoxia and interfering with fetal 
brain development, and epigenetic changes (such as the 
regulation, by DNA methylation, of the brain-derived 
neurotrophic factor BDNF-gene, important for normal 
brain development) [19].
Later obesity and related comorbidities
There is growing concern that perinatal exposure 
to chemical insults may play a significant role in the 
increased incidence of obesity and metabolic disorders 
[20]. A recent meta-analysis of 17 studies found that chil-
dren of mothers who smoked during pregnancy had an 
increased risk of obesity at a mean age of 9  years com-
pared with children of non-smoker mothers [20]. Simi-
larly another meta-analysis [21], reported that children 
whose mothers smoked during pregnancy had a 50  % 
increased risk of later overweight compared with chil-
dren whose mothers did not smoke during pregnancy. 
An Australian Prospective Birth Cohort Study [22] 
found that mean BMI and the prevalence of overweight 
and obesity among adolescents whose mothers smoked 
before and/or after pregnancy but not during pregnancy 
were similar to outcomes in adolescents whose moth-
ers had never smoked. These findings may suggest some 
evidence for a direct effect of maternal smoking in utero 
on the later development of obesity in offspring [22], as 
suggested also by another recent study [23]. Moreover 
a dose–response association between maternal preg-
nancy smoking and obesity could exist [23]. However it is 
important to point out that in these studies BMI is used 
as primary outcome but this approach could not provide 
correct information about body composition. Leary et al. 
[24] found that maternal smoking at any time during 
pregnancy has been associated with higher total fat mass 
(assessed by Dual-energy X-ray absorptiometry) in the 
offspring at mean age 9.9 years [24].
Recently a study reported that parental smoking during 
maternal pregnancy may be associated with an increased 
risk of childhood overweight [25]. Also other studies 
found an association between paternal smoking and BMI 
or adiposity [24, 26]. However further studies are needed 
to find a possible link between paternal smoking and risk 
of obesity in children.
Different mechanisms and pathways have been pro-
posed to explain the association between smoking dur-
ing pregnancy and risk of overweight and obesity such as 
thrifty phenotype theory, postnatal catch-up growth and 
neurotransmitter or endocrine imbalances [27]. Mater-
nal smoking during pregnancy may result in lower fetal 
growth and more rapid postnatal weight gain, which are 
both associated with risk of adiposity later in life [21]. 
Additionally Ino [20] suggested two different mecha-
nisms to explain the development of obesity in offspring 
of mothers who smoked. Firstly, obesity in the offspring 
of mothers affected by nicotine-inducted starvation dur-
ing early gestation could be due to altered hypothalamic 
regulatory mechanisms of energy intake and expenditure 
[20]. Secondly, fetal exposure to nicotine seems to cause 
abnormal cell proliferation, differentiation and synaptic 
activity in the brain and the peripheral autonomic path-
ways [20]. However, as tobacco smoke contains a great 
number of chemicals, it is difficult to fully understand the 
mechanisms which could determine obesity later in life.
Later cardiovascular outcomes
Maternal smoking during pregnancy may have a persis-
tent influence also on offspring cardiovascular health. 
Indeed prenatal tobacco exposure has been associated 
with lower Fetal Heart Rate Variability (HRV) in utero 
[28].
Hypertension is considered another of the health con-
sequences associated with in utero exposure to tobacco 
smoking [7]. Different studies have found an associa-
tion of maternal smoking during pregnancy with higher 
systolic or diastolic blood pressure (BP) in childhood 
[29–31]. Moreover, it has been suggested that prenatal 
maternal smoking could influence child BP with a persis-
tent effect even if mother quits months before pregnancy 
[29]. A recent study [32] showed that maternal smoking 
during pregnancy may have a small long-term effect on 
late adolescent/young adult offsprings BP but whether 
this association persists later in life is uncertain.
The involved mechanisms to explain elevated blood 
pressure in offspring, associated with maternal tobacco 
smoking, could be endothelial dysfunction, changes in 
renal structure and function, and alterations in perivas-
cular adipose tissue, important modulator of vascular 
function [7]. Maternal smoking was also associated with 
long-lasting reprogramming of infant blood pressure 
control mechanisms [33]. Indeed infants exposed to nic-
otine during fetal life have a “hyperreactive” autonomic 
system in the first few weeks of postnatal life and a dif-
ferent parasympathetic and sympathetic control at 1 year 
of age, which consequently may cause abnormal BP con-
trol on tilt testing [33]. Moreover a positive relationship 
between maternal smoking in pregnancy and shortened 
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telomere length of the fetus at birth was shown [34]. 
However it should be pointed out that a study found a 
similar effect of maternal and paternal smoking on off-
spring BP [35], suggesting that differences in child BP 
associated with maternal smoking may be not a result 
of biological effects on the intrauterine environment but 
rather a marker for parental factors [35].
Overall these findings suggest that one of strategies for 
prevention of adulthood cardiovascular disease (in par-
ticularly, high BP) should be focused on avoiding tobacco 
smoking during the conception and pregnancy period.
Respiratory outcomes
Maternal smoking during pregnancy has been associated 
with increased risk of wheezing, asthma, airway hyper 
responsiveness, impaired lung function, bronchitis [36].
A recent systematic review and meta-analysis [37] 
reported that in utero tobacco exposure is associated 
with increased risk of asthma and wheeze in children and 
adolescents up to the age of 18 years, with the strongest 
effect for incidence of asthma in children aged ≤2 years.
Childhood asthma is a chronic inflammatory disease 
of the airways, characterized by a dysregulated T-helper 
(TH) type-2 response to inhaled antigens with the con-
sequent production of IgE. From the observation that 
maternal smoke during pregnancy was associated with 
increased neonatal TH2 cytokine responses to allergens 
[38] and that nicotine could increase the production of 
cellular mediators, which in turn enhance TH2 activ-
ity and increase the production of immunoglobulin, it 
has been suggested that in utero tobacco exposure may 
enhance allergic inflammatory responses [36].
Different studies reported that in utero tobacco expo-
sure has been associated with a decrease in lung func-
tion, with a reduction of tidal and forced expiratory flow 
rates, suggestive of the affection of small airway devel-
opment [39]. A recent study found that this lower lung 
function seems to persist into adolescence with an inde-
pendent increased risk of asthma [40]. In utero tobacco 
exposure could increase oxidative stress in the lungs with 
a consequent reduced alveolarization and impaired lung 
development [39]. However further research is needed to 
better understand these mechanisms.
Tobacco smoking during lactation
One of the most significant and susceptible periods after 
birth in which parental tobacco smoke may have critical 
effects is during lactation and breastfeeding. Breastfeed-
ing by a mother who smokes is a key source of infant 
exposure to tobacco compounds as nicotine is readily 
available in breast milk [41].
It has been suggested that the deleterious effects of nic-
otine transferred into breast milk depend on the number 
of cigarettes consumed by the mother per day and also 
on the time interval between the last inhaled cigarette 
and the beginning of breastfeeding [42, 43]. The amount 
of nicotine found in breast milk is more than double 
that nicotine circulating in maternal serum (according 
to some studies 2.9 greater) and this is a relevant matter 
because is not exactly known when infants develop the 
capability to completely metabolize nicotine after absorp-
tion [42, 43]. Both the quantitative and qualitative pro-
file of breast milk components are negatively modulated 
with early and late effects on the organism. For example 
maternal smoking habit, either during pregnancy and 
lactation, has been associated with a reduced content of 
n-3 long-chain polyunsaturated fatty acid (LC-PUFA) in 
breast milk [44, 45]. A recent study has shown that smok-
ing mothers have different dietary characteristics but the 
maternal dietary pattern seems not to justify the differ-
ences in milk LC-PUFA content, suggesting an important 
role of the mammary gland in synthesizing and secret-
ing LC-PUFA into the milk [45]. Indeed, in vitro, a dose-
dependent relationship between maternal smoking and 
the inhibition of the enzyme Δ5-desaturase, involved 
in the synthesis of n-3-LC-PUFA from the precursor in 
mammary gland cells, has been showed [44].
Smoking mothers represent a risk group for short 
duration of breastfeeding because they are less likely 
to breastfeed [42]. Several explanations for premature 
stopping of breastfeeding practice have been suggested: 
smoking dose-dependent adverse effects on lactational 
process, the smoking mothers feelings about their milk 
supply as inadequate, infants behaviors exacerbated by 
tobacco smoking (e.g. colic and crying) that may promote 
other types of feeding [42].
Other than a shorter duration of breastfeeding, evi-
dences that maternal smoking during lactation has 
adverse effects on the infant refer particularly to neu-
robehavioral disorders, sudden infant death syndrome 
(SIDS), metabolic and respiratory outcomes [7, 42, 43, 
46].
Results of an experimental study indicate that infants 
sleep and wake patterns seem to be affected immediately 
after their mother smoked [42]. These sleep disruptions 
could be related to nicotine: its the stimulant effects and 
the direct and indirect inhibitory activity on neuronal 
sleep promoting functions. Tobacco smoking exposure 
may also induce irritability, excessive crying, lassitude, 
colic and pallor early in life, active sleep deprivation in 
neonates and may also be associated with later memory 
and learning deficits [42, 43].
The relationship between SIDS and neonatal tobacco 
exposure may be caused by an impaired ability of adre-
nomedullary chromaffin cells to respond to hypoxic 
stress due to nicotine [7, 42].
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Moreover different studies have investigated the nega-
tive effects of the nicotine in breast milk involved in 
organ dysfunction and related diseases in adulthood [7, 
43, 46]. Recent animal model studies showed that mater-
nal smoking may induce histopathological changes in the 
lung and liver of lactating offspring through the inhibi-
tion of those mechanisms that prevent from intracel-
lular oxidative stress [7, 43]. Additionally, some authors 
reported also a relationship between nicotine exposure 
during lactation and pancreatic β-cells depletion with 
subsequent impaired glucose homeostasis [7, 43]. Fur-
ther human investigations are needed to support these 
findings.
Although the risk of overweight in childhood after pre-
natal exposure to tobacco smoking is established [20, 21], 
this association about the exposure in early postnatal life 
and especially during lactation needs to be better studied. 
Recent evidence has demonstrated a negative cumulative 
effect concerning the postnatally exposure to smoking 
that would worsen the risk of overweight compared with 
smoking exposure only during pregnancy [41, 47]. Given 
the protective, even if modest [48], role of breastfeeding 
against obesity, it seems that in a developmental criti-
cal period, as lactation, tobacco compounds via breast 
milk of smoking mothers in a dose-dependent relation-
ship may be able to contrast the beneficial properties of 
human breast milk on the risk of overweight [41, 47].
Nevertheless, in 2001, the Committee on Drugs of the 
American Academy of Pediatrics has not placed nico-
tine (and thus smoking) as a drug contraindicated during 
breastfeeding [49]. Awaiting more data on this topic, they 
suggest that breastfeeding and parental smoking may be 
less detrimental to child health than bottle-feeding and 
parental smoking [49]. Therefore benefits of breastfeed-
ing, for both mothers and children, outweigh the risks of 
smoking exposure and breast milk remains the normal 
feeding practice even if the mother does not stop smok-
ing [42].
An infant can be exposed to tobacco smoke com-
pounds not only via breast milk but also through passive 
smoking or by the contact with tobacco smoke residues, 
on parental and infant clothing, bedding, household 
items etc. [50]. Therefore, further studies are needed to 
assess the additional effects of simultaneous second- and 
third-hand smoking exposure on infant health.
Results and conclusions
Findings from this article indicate that prenatal and early 
postnatal periods have a critical role in the individual 
outcome, as Barker affirms: “Much of human develop-
ment is completed during the first 1000  days after con-
ception” [51]. There is overall consistency in literature 
about negative effects of fetal and postnatal exposure to 
parental tobacco smoking on several outcomes: preterm 
birth, fetal growth restriction, low birth weight, sudden 
infant death syndrome, neurodevelopmental and behav-
ioral problems, obesity, hypertension, type 2 diabetes, 
impaired lung function, asthma and wheezing (Table 1). 
While maternal smoking during pregnancy plays a major 
role on adverse postnatal outcomes, it may also cumulate 
negatively with smoking during lactation and with sec-
ond-hand smoking exposure.
This review aimed to discuss the current evidence 
regarding the short and long-term effects of parental 
tobacco smoking during a critical period of life (preg-
nancy and lactation). It should be pointed out that 
it was not strictly designed a priori as a systematic 
review, and that the PRISMA Statement was not fully 
applied (including PICOS). Although this is a weak-
ness, a descriptive approach might benefit the reader 
Table 1 Parental tobacco smoking and offspring health outcomes
a Proved in vitro and/or in animals
b Hypothesized in humans
Parental tobacco smoking Health outcomes
Short-term Long-term
During pregnancy
Maternal smoking Preterm birthb
Fetal growth restrictionb
Low birth weightb
Altered brain structure and function in newbornsb
Lower fetal heart rate variabilityb
Reduced alveolarizationb
Increased risk of overweight and obesitya,b
Higher blood pressurea,b
Increased risk of wheezing, asthma, airway hyperrespon-
siveness, impaired lung function, bronchitisb
Paternal/environmental smoking Low birth weightb Further studies are needed
During lactation
Maternal smoking Increased risk of sudden infant death syndrome (SIDS)b
Neurodevelopmental and behavioral disordersb
Sleep disruptionb
Increased risk of overweight and obesitya,b
Impaired glucose homeostasisa
Increased risk of respiratory allergy (asthma and rhinitis)a,b
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with a promptly and friendly readable update of the 
matter.
The results of this review strengthens the need to plan 
population health policies aimed to implement educa-
tional programs to hopefully minimize tobacco smoke 
exposure during pregnancy and lactation. Mothers 
should be strongly encouraged to stop smoking espe-
cially during pregnancy and lactation. Parents should 
know that exposure to prenatal and postnatal tobacco 
smoking is associated with different adverse outcomes 
and that tobacco smoking is one of the most preventable 
causes of infant morbidity and mortality [52]. However, 
breastfeeding is the best way of infant feeding even if a 
mother doesn’t quit smoking during lactation [49]. Amal-
gamating results from different studies, this paper could 
be a useful tool to educate and increase awareness about 
adverse health effects of parental tobacco smoking for 
children. Additionally, it could be a starting point for the 
conception of new health promotion and public health 
campaigns that emphasize the importance of parental 
smoking cessation.
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